The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Lyxor Russell 2000 UCITS ETF - Acc: Net Asset Value(s)

14 Nov 2019 14:54

Lyxor Russell 2000 UCITS ETF - Acc (RU2K LN) Lyxor Russell 2000 UCITS ETF - Acc: Net Asset Value(s) 14-Nov-2019 / 15:53 CET/CEST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Net Asset Value(s)

FUND: Lyxor Russell 2000 UCITS ETF - Acc

DEALING DATE: 13-Nov-2019

NAV PER SHARE: USD: 230.3979

NUMBER OF SHARES IN ISSUE: 40920

CODE: RU2K LN

ISIN: FR0011119254


ISIN:FR0011119254
Category Code:NAV
TIDM:RU2K LN
Sequence No.:29199
EQS News ID:913199
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.